Skip to Main Content (Press Enter)

Logo UNINSUBRIA
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Projects
  • Expertise & Skills

UNI-FIND
Logo UNINSUBRIA

|

UNI-FIND

uninsubria.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Projects
  • Expertise & Skills
  1. People
Person
CARRO MARIA STELLA

CARRO MARIA STELLA

Ricercatori a tempo determinato
DIPARTIMENTO DI MEDICINA E INNOVAZIONE TECNOLOGICA
Course Catalogue:
https://uninsubria.coursecatalogue.cineca.it/docen...

Gruppo 06/MEDS-02 - PATOLOGIA GENERALE E PATOLOGIA CLINICA

Settore MEDS-02/A - Patologia generale
  • Contact
  •  mariastella.carro@uninsubria.it
  •  0332 39 7606
  • Alerts
  • Overview
  • Cv
  • Research Fields
  • Affiliation
  • Projects
  • Outputs
  • Prizes And Scientific Assignments
  • Other Activities
  • Courses
  • Third Mission
  • Office Hours
  • Useful Resources

Communications

Overview

During my scientific career, I have developed strong expertise in cancer research, initially as a postdoctoral researcher at the IEO-IFOM Campus in Milan and later at the Institute for Cancer Genetics, Columbia University, where I focused on brain tumor research. My work aims to identify deregulated signaling, transcriptional, genetic, and epigenetic mechanisms driving glioblastoma (GBM) aggressiveness and affecting patient survival. A major achievement of my postdoctoral work was the identification of master regulators of the mesenchymal signature in glioma. In a Nature publication (2010), I demonstrated the critical role of STAT3 and C/EBPβ in gliomagenesis, providing the first comprehensive mapping of transcription factors controlling the mesenchymal GBM phenotype. After establishing my independent research in Germany with support from Marie Curie and DFG grants, I extended my studies through systems biology and epigenetic approaches, identifying ANXA2 as an epigenetically regulated gene linked to mesenchymal gene expression and patient survival. As group leader at the University of Freiburg, I characterized ZBTB18 as a tumor suppressor in GBM, showing that its loss promotes invasive mesenchymal traits, lipid biosynthesis, and tumor-promoting microglia recruitment. This work, previously supported by the German Cancer Aid, is now expanded at the University of Insubria.

Attachment (CV)

CV_CARRO.docx (Carro CV)

Description

EDUCATION
2023–present – Abilitation in General and Clinical Pathology (06/A2), Italy
2019 – Abilitation, Experimental Medicine, University of Freiburg
2002 – PhD in Developmental Biology, University of Milan
1998 – MSc in Biology, University of Insubria
ACADEMIC APPOINTMENTS
1 Sept 2024 – Present
Assistant Professor (RTDb), Laboratory of General Pathology and Immunology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy
1 Oct 2012 – 31 Aug 2024
Group Leader, Neuro-oncology Unit, Department of Neurosurgery, University Medical Center Freiburg, Germany
1 Oct 2009 – 30 Sept 2012
Team Leader, Neuro-oncology Laboratory, Department of Neurosurgery, University Medical Center Freiburg, Germany
1 Sept 2005 – 30 Sept 2009
Postdoctoral Research Scientist, ICG, Columbia University, New York, USA
1 June 2002 – 31 Aug 2005
Postdoctoral Researcher, IEO (European Institute of Oncology), Milan, Italy
1 Nov 1998 – 30 June 2002
PhD Candidate, Department of Functional and Structural Biology, University of Insubria, Varese, Italy
SELECTED PUBLICATIONS
1) Ferrarese, R. et al. and Carro M.S. ZBTB18 regulates cytokine expression and affects microglia/macrophage recruitment and commitment in glioblastoma. https://doi.org/10.1038/s42003-024-07144-y
2) R. Ferrarese et al. and M.S. Carro. ZBTB18 inhibits SREBP-dependent lipid synthesis by counteracting CTBPs and KDM1A/LSD1 activity in glioblastoma. doi: 10.26508/lsa.202201400.
3) A. P Masilamani et al. and M. S. Carro. Calpain-mediated cleavage generates a ZBTB18 N-terminal product that regulates HIF1A signaling and glioblastoma metabolism. doi:10.1016/j.isci.2022.104625.
4) Fedele V. et al. and Carro MS. Epigenetic regulation of ZBTB18 promotes glioblastoma progression. doi: 10.1158/1541-7786.MCR-16-0494.
5) Ferrarese R. et al. and Carro MS*, Bredel M*.Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. doi: 10.1172/JCI68836.

Overview

My scientific activity focuses on characterizing the molecular mechanisms associated with the progression of glioblastoma (GBM), the most aggressive and deadly brain tumor in adults. This tumor is characterized by high plasticity and heterogeneity, with cells in different states reminiscent of different developmental stages. MES-like cells contain a high percentage of slow-cycling cells, termed quiescent GBM (qGBM), which are important for therapy resistance and for evading immune surveillance, contributing to the immunosuppressive environment of GBM. We have previously identified ZBTB18 as a transcriptional repressor of MES genes and a tumor suppressor in GBM. The group is currently involved in several projects aimed at better understanding the role of ZBTB18 and associated factors in maintaining quiescence and regulating tumor antigen expression.
No Results Found

Member of

Molecular Neuro-oncology
Group

Other research activities

Dissecting the contribution of ZBTB18 and TIP60 complex to the mesenchymal/quiescent state in GBM 
Progetti interamente finanziati dall'Ateneo
Project
Scientific Manager
2026
12 months
No Results Found

Publications (29)

  • ascendant
  • decrescent
  • All
  • All
  • Open
  • Partially Open
  • Mixed
  • Embargoed
  • Reserved

Research and teaching at institutions (3)

Position carried out at: Università degli Studi INSUBRIA Varese-Como - Ricercatore/Ricercatrice universitario a t.d. (01/09/2024 - 31/08/2027)20240901
Group leader at: Albert-Ludwigs-Universität Freiburg - Ricercatore/Ricercatrice all’estero (01/10/2012 - )20121001
Senior post-doc/team leader at: Albert-Ludwigs-Universität Freiburg - Ricercatore/Ricercatrice all’estero (01/10/2009 - 30/09/2012)20091001
No Results Found

Tutoring

tutorship - Altro - ZANZI LUCREZIA
No Results Found

Courses (11)

  • ascendant
  • decrescent

DMC0580 - BIOLOGY

Primo Semestre (01/09/2025 - 15/11/2025) - 2025
6 CFU
75 hours

MED0428 - BIOMEDICAL SCIENCES

Secondo Semestre (03/03/2025 - 20/05/2025) - 2025
8 CFU
76 hours

MED0428-2 - GENERAL PATHOLOGY

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
1 CFU
12 hours

MED0471 - PATHOPHYSIOLOGICAL FOUNDATIONS OF LIFE

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
5 CFU
66 hours

MED0471 - PATHOPHYSIOLOGICAL FOUNDATIONS OF LIFE

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
5 CFU
66 hours

MED0471-2 - GENERAL PATHOLOGY

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
3 CFU
36 hours

MED0471-2 - GENERAL PATHOLOGY

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
3 CFU
36 hours

SME0054 - IMMUNOLOGY AND GENERAL PATHOLOGY - CO

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
2 CFU
30 hours

SME0056 - CLINICAL PATHOLOGY - CO

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
1 CFU
15 hours

SME0405 - GENERAL PATHOLOGY AND PHARMACOLOGY

Secondo Semestre (02/03/2026 - 05/06/2026) - 2025
5 CFU
75 hours

SME0593 - BIOLOGY

Primo Trimestre (01/09/2025 - 15/11/2025) - 2025
6 CFU
75 hours
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} of {itemsNumber}

Third Mission (2)

Attività di coinvolgimento e interazione con il mondo della scuola (Responsabile scientifico) - Partecipazione alla notte dei ricercatori con il laboratorio AIRC "Diversi da chi"
DIPARTIMENTO DI MEDICINA E INNOVAZIONE TECNOLOGICA
Ateneo e villa Mirabella (26/09/2025 - 27/09/2025) 20250926
Attività di coinvolgimento e interazione con il mondo della scuola (Responsabile scientifico) - Partecipazione alla notte dei ricercatori con il laboratorio AIRC "mangiamo veramente?"
DIPARTIMENTO DI MEDICINA E INNOVAZIONE TECNOLOGICA
Ateneo e Piazza Montegrappa (Varese) (27/09/2024 - ) 20240927
No Results Found

Office Hours

Video

Useful Resources

  • Accessibility
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.4.5.0